Details of the Drug Reposition | DrugMAP

General Information of This Drug (ID: DMNAT5V)

Drug Name	GW-2592X DMNAT5V
Synonyms	Azepanone inhibitors, GlaxoSmithKline; Cathepsin K inhibitors (bone disorder); Cathepsin K inhibitors, SmithKline Beecham; GW-2637X; GW-2934X; GW-9696X; SB-237632; SB-244875; SB-267320; SB-271194; SB-327537; SB-331750; SB-357114; SB-432238; SB-553484; Cathepsin K inhibitors (bone disorder), GlaxoSmithKline
Structure	3D Structure is Not Available
Structure	3D MOL			2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

1 Preclinical Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Osteoporosis	DISF2JE0	FB83.0	Preclinical	[1]
------------------------------------------------------------------------------------

1 Investigative Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Bone disease	DISE1F82	FC0Z	Investigative	[2]
------------------------------------------------------------------------------------

References

1	Lysosomes as a therapeutic target. Nat Rev Drug Discov. 2019 Dec;18(12):923-948.
2	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2350).